GlassScriptPhysician profile
Michael Montuno
NPI 1164841797
$1,567.27
in general payments reported to CMS, 2019-2025
13 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $100 · 2021: $122 · 2022: $40.31 · 2023: $101 · 2024: $582 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $630.04 | 2023-2025 | Novachor, Affinity, Cygnus Dual |
| Sun Pharmaceutical Industries INC. | $192.09 | 2020-2022 | |
| Abbvie INC. | $178.54 | 2019 | |
| Mimedx Group, INC. | $128.82 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $127.66 | 2022-2025 | Libtayo |
| Amgen INC. | $102.00 | 2024 | Otezla |
| Kerecis Limited | $77.65 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Genentech USA, INC. | $30.75 | 2020 | |
| Ets Wound Care LLC | $27.24 | 2024 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $23.85 | 2020 | |
| Pfizer INC. | $19.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.40 | 2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Montuno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.